QID® / Screening

    • Updated

    Qid® is the world’s first microtransponder for clinical use in a breast implant. It is the only transponder with a CE mark (which indicates compliance with the health, safety, and environmental protection standards for products sold in the European Economic Area), and the United States Food & Drug Administration (FDA) cleared it for use in 2004. Qid® is placed in the gel filling inside Motiva® Implants.

    A handheld reader is used to externally scan the transponder, providing an electronic serial number (ESN) that can be used to retrieve important implant information such as manufacturing date, implant type, volume, and more.

    Qid® is an optional feature in Motiva® Implants that is particularly useful to patients and surgeons to identify the implant type after the surgery, and to verify implant details during the event of a product recall.

    Product information or warranty on cards can be lost or misplaced. With its unique ESN permanently located within the breast implant, Qid® provides the confidence of instant implant traceability and verification.

     

    A radio frequency identification (RFID) microtransponder (Qid®) is a passive component (without a battery)  placed in the gel that provides each implant device with a unique electronic serial number which is only accessible through the use of a handheld scanner specific to Motiva. The Electronic serial number does not contain patient-specific or identifiable information,  only device-specific information such as the manufacturing date, serial number, lot number, implant volume, size and projection, model and surface type). 

     

     The Qid is 9mm in length.

     

    The components of the Qid® are:

    • Copper Polystermide Estersol 180 wire,
    • Nickel-Zinc Ferrite core,
    • Photobond4442 Acrylate adhesive,
    • 4305 Application Specific Integrated Circuit (ASIC),
    • and Soda-lime Silicate glass.

     
    Learn more
    • Updated

    Q Inside® Safety Technology is the world’s first micro transponder for clinical use in a breast implant. It is the only transponder with CE mark (which indicates compliance with the health, safety, and environmental protection standards for products sold in the European Economic Area), and the United States Food & Drug Administration (F.D.A.) cleared it for use in 2004. Q Inside® is placed in the gel filling inside Motiva Implants®.

    A handheld reader is used to externally scan the transponder, providing an electronic serial number (ESN) that can be used to retrieve important implant information such as manufacturing date, implant type, volume, and more.

     

    Q Inside® is an optional feature in Motiva Implants® that is particularly useful to patients and surgeons to identify the implant type after the surgery, and to verify implant details during the event of a product recall.

    Product information or warranty cards can be lost or misplaced. With its unique ESN permanently located within the breast implant, Q Inside® provides the confidence of instant implant traceability and verification.

     

    Qid® does not pose any safety concerns for patients. It has been proven to be both safe and effective. Activated externally by the reader, it doesn’t require a battery and has an indefinite life expectancy. Qid® is magnetic resonance (MR) conditional, meaning that it is a device that is shown not to pose any hazards under specific magnetic resonance conditions.

     

    Please see the attached documents for more information:

    - Qid facts for the surgeon

    - Qid facts for radiologists

    Learn more
    • Updated

    MRI scanning is the imaging modality of choice for breast implant rupture surveillance or diagnosis. In the event of a suspected rupture of a Motiva® implant with Qid®, MRI should be the first imaging method of choice.

    Qid® is a small, light device comprised of an integrated circuit and ferrite coil/antenna assembly. Due to the presence of the ferrite, an MRI of Motiva® Implants with Qid® may produce a shadow, known as an artifact, immediately behind the device. If a rupture is not found but is suspected in this specific area, a second imaging modality (such as ultrasound, tomosynthesis, digital compression mammography, subtraction contrast mammography, and/or scintimammography) may be used to better visualize the obstructed region.

    For more information, please refer to your Directions for Use document received with your Motiva® product and our INFORMATION FOR THE PATIENT document.

    Learn more
    • Updated

    Artifacts are commonplace in MRI and may cause visualization challenges when reading tissue structures. Artifacts may be present as shadows, distortions or voids within the imaging field and can be caused by a variety of phenomena such as:

    • The underlying physics of the energy-tissue interaction
    • Possible data acquisition errors (e.g., the patient moved during scanning)
    • Presence of metallic objects (orthopedic hardware, vascular ports, pacemakers)

    Breast implants themselves may interfere with imaging by creating shadows or voids, which obscure areas of tissue within the breast and create difficulties in obtaining a clear mammography of the entire breast. If you are unfamiliar with the previously mentioned terminology and would like to learn more, please contact your doctor and/or surgeon.

    For more information, please refer to your Directions for Use document received with your Motiva® product and our INFORMATION FOR THE PATIENT document.

    Learn more
    • Updated

    The microtransponder (Qid®) is MRI-safe. The device is “MRI conditional”, meaning that it has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use.

    Qid® may create an imaging void during MRI (known as an artifact effect) that can block visualization of a small area of minor breast tissue near it. In special cases, alternative imaging techniques such as ultrasound, tomosynthesis, digital compression mammography, subtraction contrast mammography, and/or scintimammography can be used to better visualize the region obstructed by Qid®.

    For more information, please refer to the attached documents 'Qid facts for surgeons and radiologists'.

     

    Learn more
    • Updated

    The risks associated with the microtransponder include the following:

    • Adverse tissue reaction
    • Migration of the transponder
    • Failure of the microtransponder to operate properly
    • Failure of the inserter
    • Failure of the electrical scanner
    • Electromagnetic interference
    • Electrical hazards
    • MRI disturbances

    These risks have been mitigated through the establishment of certain testing requirements by the FDA for this device, including the requirement to perform biocompatibility testing, migration testing, performance testing, electromagnetic compatibility testing, electrical safety testing, and MRI compatibility testing.

    Learn more
    • Updated

    Currently, MRI imaging is the preferred method of choice for identification of implant rupture in breast implant evaluation. However, there are other technologies that may be used in addition to MRI and are recommended complement visualization and improve overall diagnosis. Additional imaging modalities to be considered include the following:

    • Breast ultrasound.
    • Digital tomosynthesis.
    • Automated ultrasound.
    • Scintimammography.
    • Dual energy contrast subtraction digital mammography.
    • Dual-energy enhanced mammography.

    If you are unfamiliar with the previously mentioned terminology and would like to learn more, please contact your doctor and / or surgeon.

    Learn more

Contact Motiva®!

Have another question? Send us a message!

Request support